Wyeth's 'Medical Ghostwriting' Docs To See Daylight
The judge in charge of the multidistrict litigation over Wyeth Pharmaceuticals Inc.'s drug Prempro has unsealed discovery pertaining to "medical ghostwriting," granting a bid from a medical journal seeking to expose...To view the full article, register now.
Already a subscriber? Click here to view full article